# FDA Inspection 1214821 - Biomat USA, Inc. - June 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f4367bec-83cd-4219-80e8-f69795bc1030
Source feed: FDA_Inspections

> FDA Inspection 1214821 for Biomat USA, Inc. on June 28, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214821
- Company Name: Biomat USA, Inc.
- Inspection Date: 2023-06-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/biomat-usa-inc/75481e52-be31-4b71-8a28-90ea57306eb7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d